highperformr logo

2seventy bio's Overview

Total employees111
HeadquartersCambridge
Founded2021

2seventybio is a clinical-stage cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. Following a strategic asset sale and restructuring in 2024, the company is concentrating its efforts on advancing its core pipeline of innovative CAR T cell therapies for hematologic malignancies, aiming to bring new hope to patients with difficult-to-treat cancers.

Where is 2seventy bio's Headquarters?

HQ Function

Serves as the primary center for corporate leadership, research and development activities, clinical operations, and strategic business development for its focused oncology pipeline.

Notable Features:

State-of-the-art laboratory facilities, collaborative workspaces, and its strategic location within the dense Kendall Square biotech ecosystem, offering proximity to leading research institutions and industry peers.

Work Culture:

A dynamic, science-driven, and highly collaborative environment, intensely focused on its mission to develop life-changing therapies for cancer patients. The culture emphasizes innovation, resilience, and a patient-first mindset, typical of agile biotech firms in a leading innovation district.

HQ Significance:

Strategically situated in Kendall Square, the heart of the Boston/Cambridge biotech cluster, providing unparalleled access to scientific talent, academic collaborations (e.g., MIT, Harvard-affiliated hospitals), and a vibrant network of biotech companies and investors, crucial for advancing its cell therapy programs.

Values Reflected in HQ: The headquarters' location and design reflect 2seventybio's commitment to cutting-edge science, collaboration, and innovation. The advanced facilities support rigorous research and development, while its presence in Kendall Square fosters external collaboration and access to the latest scientific breakthroughs.

Location:

Following its 2024 restructuring, 2seventybio's physical presence is primarily consolidated in Cambridge, MA. However, its global reach is maintained through clinical trial operations for its pipeline candidates, which may involve sites and patients in multiple countries. The company may also engage in international collaborations with research institutions and consider global regulatory and commercialization strategies for its therapies.

Street Address:

60 Binney Street

City:

Cambridge

State/Province:

MA

Country:

USA

2seventy bio's Global Presence

Cambridge, MA, USA (Former Manufacturing)

Address: 150 Second Street, Cambridge, MA 02142 (Former Site)

Formerly supported clinical and potential commercial manufacturing needs for the company's cell therapy programs in the U.S.

Seattle, WA, USA (Former R&D)

Address: 2001 Westlake Avenue North, Seattle, WA 98109 (Former Site)

Formerly contributed to the company's R&D pipeline and innovation, leveraging the U.S. West Coast biotech ecosystem.

Buying Intent Signals for 2seventy bio

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of 2seventy bio

As of April 2025, 2seventy bio' leadership includes:

Chip Baird - Chief Executive Officer
Steve Bernstein, M.D. - Chief Medical Officer
Olubunmi (Good) Olanrewaju, Pharm.D. - Chief Development Officer

Investors of 2seventy bio

2seventy bio has been backed by several prominent investors over the years, including:

The Vanguard Group
BlackRock Inc.
FMR LLC (Fidelity)
State Street Corporation
Janus Henderson Group PLC
Various other institutional and individual shareholders (as a publicly traded company)

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits1

Over the past 12 months, 2seventybio underwent a significant strategic restructuring, including changes in executive leadership. Key changes involved Nick Leschly transitioning to Chairman, Chip Baird becoming CEO, and the departure of former CFO Chris Krawtschuk. These changes reflect the company's sharpened focus after its asset sale to Regeneron.

Departures

Chris Krawtschuk, Chris Krawtschuk departed from his role as Chief Financial Officer.

New Appointments:

Chip Baird, Chip Baird appointed as new CEO, promoted from Chief Operating Officer, following strategic restructuring.
Nick Leschly, Nick Leschly transitioned from an operational leadership role (Chief Kairos Officer) to Chairman of the Board.

Technology (Tech Stack) used by 2seventy bio

Discover the tools 2seventy bio uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

2seventy bio Email Formats and Examples

2seventybio likely utilizes common corporate email formats. The most probable patterns include [first initial][last name]@2seventybio.com (e.g., jdoe@2seventybio.com) and [first name].[last name]@2seventybio.com (e.g., jane.doe@2seventybio.com). For important communications, verification is recommended.

[first_initial][last]@2seventybio.com

Format

jdoe@2seventybio.com

Example

90%

Success rate

News and media

2seventybio Press ReleaseMay 2, 2024

2seventybio Completes Asset Purchase Agreement with Regeneron and Provides Corporate Updates

2seventybio announced the completion of the sale of its portfolio of discovery and clinical-stage oncology and autoimmune R&D programs to Regeneron Pharmaceuticals. The company also detailed a strategic restructuring to focus on advancing its core CAR T pipeline, primarily the bbT369 program, with a significantly reduced workforce and a new leadership team....more

2seventybio Press ReleaseMay 2, 2024

2seventybio Reports First Quarter 2024 Financial Results and Provides Business Update

Coinciding with its restructuring news, 2seventybio reported its Q1 2024 financial results. The report detailed its financial standing after the Regeneron deal, revised operational plans, and reaffirmed its commitment to developing its core cell therapy assets for patients with cancer....more

2seventybio Press ReleaseMay 28, 2024

2seventybio to Participate in Jefferies Healthcare Conference

2seventybio announced its participation in the Jefferies Healthcare Conference in June 2024. This provided an early opportunity for the new leadership team to present the company's updated strategy, pipeline focus, and future outlook to the investment community following its recent transformation....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including 2seventy bio, are just a search away.